首页> 外文OA文献 >MO040SYNERGETIC B-CELL IMMUNOMODULATION WITH RITUXIMAB AND BELIMUMAB IS CLINICALLY EFFECTIVE IN SEVERE AND REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS - THE SYNBIOSE PROOF-OF-CONCEPT STUDY

【2h】

MO040SYNERGETIC B-CELL IMMUNOMODULATION WITH RITUXIMAB AND BELIMUMAB IS CLINICALLY EFFECTIVE IN SEVERE AND REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS - THE SYNBIOSE PROOF-OF-CONCEPT STUDY

机译：用Rituximab和Belimumab的MO040Synergetic B细胞免疫调节在严重和难治性系统性狼疮红斑狼疮中临床有效 - Synbiose验证研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Tineke Kraaij; Sylvia Kamerling; Esther de Rooij; Paul van Daele; Ingeborg Bajema; Obbo Bredewold; Tom Huizinga; Ton Rabelink; Cees van Kooten; Y.K. Onno Teng;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies [J] . Luca Petricca, Stefano Alivernini, Giuseppe Grandaliano, Frontiers in Medicine . 2020,第a期

机译：Rituximab后跟Belimeab对照系统狼疮红肿的严重狼疮肾炎和大疱性Pemphigoid，以几种组合疗法难治
2. Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies [J] . Petricca Luca, Gigante Maria Rita, Paglionico Annamaria, Frontiers in Medicine . 2020,第2期

机译：Rituximab后跟Belimumab在Systemicic Lupus红斑狼疮中对照狼疮性肾炎和大疱性肺炎难以进行几种组合疗法
3. Severe acute thrombotic exacerbation in two cases with anti-phospholipid syndrome after retreatment with rituximab in phase I/II clinical trial for refractory systemic lupus erythematosus [J] . K. Suzuki1 H. Nagasawa1 H. Kameda1 K. Amano1 T. Kondo1 S. Itoyama2 Y. Tanaka3 and T. Takeuchi1 Rheumatology . 2009,第2期

机译：I / II期难治性系统性红斑狼疮I / II期临床试验中利妥昔单抗复治后的2例抗磷脂综合症的严重急性血栓形成加重
4. Plasma Exchange Plus Mycophenolate Mofetil, Hormones with Severe Systemic Lupus Erythematosus Serum Autoantibodies [C] . Shuai Ping, Guo Dang International Conference on Advanced Materials and Computer Science . 2016

机译：血浆交换加霉霉素Mofetil，激素具有严重的Systemic狼疮红斑狼疮血清自身抗体
5. Acquired Low Immunoglobulin Levels and Risk of Clinically Relevant Infection in Adult Patients with Systemic Lupus Erythematosus Cohort Study [D] . Almaghlouth, Ibrahim Ali S. 2019

机译：在成人狼疮患者中获得低免疫球蛋白水平和临床相关感染的风险红斑狼疮队列队列研究
6. Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies [O] . Luca Petricca, Maria Rita Gigante, Annamaria Paglionico, 2020

机译：Rituximab后跟Belimumab在Systemicic Lupus红斑狼疮中对照狼疮性肾炎和大疱性肺炎难以进行几种组合疗法
7. P127 Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory SLE: two year results rituximab and belimumab combination for severe SLE [O] . Tineke Kraaij, Eline J Arends, Laura S van Dam, 2020

机译：P127与Rituximab和Belimumab组合B细胞免疫调节的长期影响严重，难治性SLE：两年结果Rituximab和Belimalab对严重SLE的组合

MO040SYNERGETIC B-CELL IMMUNOMODULATION WITH RITUXIMAB AND BELIMUMAB IS CLINICALLY EFFECTIVE IN SEVERE AND REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS - THE SYNBIOSE PROOF-OF-CONCEPT STUDY

著录项

相似文献

相关主题

期刊订阅